跳至主要内容
临床试验/ISRCTN62596811
ISRCTN62596811进行中(未招募)未知

Effects on cervical high-risk human papillomavirus clearance in patients undergoing treatment with vaginal gel based on carboxy-methyl-beta-glucan in polycarbophil plus an oral probiotic containing L. rhamnosus TOM 22.8 strain: a randomized controlled trial

Ospedale dei Bambini Vittore Buzzi0 个研究点目标入组 80 人开始时间: 2022年9月11日最近更新:

试验速览

阶段
未知
状态
进行中(未招募)
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
Female

入选标准

  • 1. Women aged 30-45 years
  • 2. Persistent positive cytological LSIL and/or histological CIN 1 and/or HPV HR test for at least 12 months
  • 3. Absence of contraindications to the proposed therapies
  • 4. Read and signed informed consent

排除标准

  • 1. Active vulvovaginal infections at the time of their gynaecological examination
  • 2. Genital bleeding of unknown origin
  • 3. Pregnancy
  • 4. Menopause (absence of menstruation for 12 months)
  • 5. Diagnosis of or under therapy for previous CIN2+ lesions
  • 6. Immune-depressed, or with infections caused by human immunodeficiency virus (HIV-positive)
  • 7. Patients concomitantly included in different interventional clinical trials
  • 8. Unwillingness to provide informed consent to the trial

研究者

相似试验